Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
G.VillanuevaC.AracilC.TurnesJ.Hernandez-GuerraM.GenescaJ.et al (2016)
During your consultation, a SwiftDoctor clinician will review your eligibility based on your BMI, any weight-related health conditions, and your current medications, and will confirm which GLP-1 option, if any, is clinically appropriate
Despite their established role in promoting weight loss, there is a paucity of research investigating the safety or efficacy of GLP-1RAs in people whose eating disorders have a psychopathological component (for example, anorexia nervosa, bulimia nervosa) as conventionally defined by diagnostic manuals
This study examined whether people who started a glucagon-like peptide-1 receptor agonist (GLP-1) like Zepbound or Ozempic were less likely to develop a substance use disorder, and whether people who already had a substance use disorder had fewer serious complications
